IL17A and cardiovascular disorder: Recent studies have highlighted the role of IL-17A in connecting cardiovascular disease (CVDs) with psoriatic inflammation, suggesting that anti-IL-17A therapy could not only benefit skin conditions but also reduce cardiovascular inflammation.